Commitment to Enhancing Corporate Value and Expanding Business Performance over the Medium to Long Term through Stock Options
First written in FY2017-Q1. 6 of 7 entries say "Advanced", first in FY2017. Latest entry: FY2025.
- FY2025AdvancedAnnual report
「The 13th, 14th and 15th Series Stock Acquisition Rights have been issued.」
The performance-based 13th Series and the staged-vesting 14th and 15th Series Stock Acquisition Rights continued to link long-term corporate value and business growth to performance. - FY2025-H1AdvancedAnnual report
「(2) 14th Series Stock Acquisition Rights (Resolution of the Board of Directors dated 25 March 2025) Number of stock acquisition rights (rights)* 792 (Note) 1 Number of shares underlying the stock acquisition rights (shares)* 79,200 (Note) 1」
The 14th Series Stock Acquisition Rights were issued, granting rights covering 79,200 shares to directors, executive officers and employees. Staged vesting conditions from 2028 through 2030 were also established. - FY2024AdvancedAnnual report
「To further increase motivation and morale and strengthen the commitment to business growth while seeking to enhance the company's corporate value over the medium to long term, paid stock acquisition rights will be issued to the company's directors and employees.」
A total of 21,576 13th Series Stock Acquisition Rights were issued to 33 directors and employees, with conditions linked to revenue, SaaS ARR, EBITDA and adjusted operating cash flow margin. - FY2023-Q1AdvancedAnnual report
「12th Series Stock Acquisition Rights (Resolution of the Board of Directors dated 23 January 2023)」
A total of 11,660 12th Series Stock Acquisition Rights, covering 1,166,000 common shares, were issued, with an exercise period from 1 March 2025 to 28 February 2030. - FY2018-Q1AdvancedAnnual report
「11th Series of Share Acquisition Rights (resolution of the Board of Directors dated 15 January 2018)」
The 11th Series Stock Acquisition Rights were issued pursuant to a resolution of the Board of Directors. A total of 3,200 rights, covering 320,000 shares, were issued, with an exercise period from 5 February 2019 to 4 February 2025. The exercisable percentage was determined according to revenue conditions for the fiscal years ending November 2018 through November 2020. - FY2017AdvancedAnnual report
「To further increase motivation and morale and strengthen the commitment to business growth while seeking to enhance the company's corporate value over the medium to long term, paid stock acquisition rights will be issued to officers and employees of the company and its subsidiaries.」
The issuance of paid stock options covering 320,000 common shares to directors and employees of the company and its subsidiaries was approved. - FY2017-Q1First statedAnnual report
「We will issue share acquisition rights as stock options to our directors and employees free of charge, with the aim of further increasing their motivation and morale and strengthening their commitment to business expansion as we seek to increase corporate value over the medium to long term.」
The company announced a policy of issuing a total of 18,650 stock acquisition rights to directors, employees, outside directors, audit & supervisory board members and external collaborators. The exercise period was set from 15 March 2020 to 14 March 2026.